Paul J Kurtin Selected Research

Paul J Kurtin Research Topics

Disease

25	Amyloidosis 09/2022 - 02/2004
17	Neoplasms (Cancer) 01/2020 - 11/2002
13	Amyloid Plaque 09/2022 - 03/2014
11	Lymphoma (Lymphomas) 01/2022 - 06/2002
9	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2018 - 01/2002
5	Familial Amyloidosis (Hereditary Amyloidosis) 11/2018 - 05/2014
4	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2011 - 07/2004
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 01/2002
3	Immunoglobulin Light-chain Amyloidosis 01/2019 - 03/2014
3	Glomerulonephritis 01/2017 - 05/2015
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2011 - 06/2006
3	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2009 - 07/2002
2	Multiple Myeloma 10/2019 - 02/2007
2	Carcinoma (Carcinomatosis) 10/2019 - 02/2005
2	Transthyretin-Related Hereditary Amyloidosis 08/2017 - 07/2014
2	Disease Progression 08/2017 - 02/2007
2	Chronic Renal Insufficiency 01/2017 - 01/2016
2	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2017 - 06/2016
2	Autoimmune Diseases (Autoimmune Disease) 06/2016 - 11/2005
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2016 - 08/2006
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2015 - 11/2002
2	Thrombocytopenia (Thrombopenia) 04/2011 - 08/2008
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2011 - 04/2003
2	T-Cell Lymphoma (Lymphoma, T Cell) 08/2008 - 08/2006
1	Hodgkin Disease (Hodgkin's Disease) 01/2022
1	Deafness (Deaf Mutism) 09/2020
1	Sensorineural Hearing Loss 09/2020
1	Stroke (Strokes) 01/2020
1	Cardiac Arrhythmias (Arrythmia) 01/2020
1	Atrial Fibrillation 01/2020
1	Acinar Cell Carcinoma 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 10/2019
1	Sepsis (Septicemia) 10/2019
1	Heart Failure 11/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2018
1	Eosinophilia 10/2018
1	Systemic Mastocytosis 10/2018
1	Pdgfra-Associated Chronic Eosinophilic Leukemia 10/2018
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 10/2018
1	Adenocarcinoma 02/2018

Drug/Important Bio-Agent (IBA)

19	Amyloid (Amyloid Fibrils)IBA 09/2022 - 02/2004
12	Proteins (Proteins, Gene)FDA Link 03/2022 - 06/2006
11	Congo RedIBA 03/2022 - 01/2013
9	Rituximab (Mabthera)FDA Link 10/2017 - 01/2002
9	ParaffinIBA 04/2015 - 01/2002
7	Peptides (Polypeptides)IBA 08/2017 - 05/2014
5	Immunoglobulins (Immunoglobulin)IBA 10/2019 - 07/2014
3	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 10/2019 - 07/2014
3	GelsolinIBA 11/2018 - 01/2013
3	Chemotactic FactorsIBA 02/2017 - 03/2014
3	Biological ProductsIBA 08/2009 - 02/2007
3	AntigensIBA 04/2005 - 09/2002
3	AntibodiesIBA 04/2005 - 01/2002
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2008
2	Carboxypeptidases A (Carboxypeptidase A)IBA 01/2020 - 10/2019
2	AA amyloidosisIBA 10/2019 - 04/2016
2	IgKIBA 11/2018 - 12/2006
2	Mutant Proteins (Protein, Mutant)IBA 11/2018 - 09/2018
2	Pharmaceutical PreparationsIBA 10/2018 - 08/2008
2	Apolipoprotein C-II (ApoC2)IBA 09/2018 - 02/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2017 - 10/2011
2	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2017 - 10/2011
2	PlatinumIBA 10/2017 - 06/2008
2	Complement System Proteins (Complement)IBA 01/2017 - 06/2016
2	apolipoprotein A-IV (apolipoprotein AIV)IBA 01/2017 - 01/2016
2	ParaproteinsIBA 06/2016 - 06/2009
2	ApolipoproteinsIBA 01/2016 - 01/2013
2	Immunoglobulin M (IgM)IBA 05/2015 - 04/2003
2	Immunoglobulin G (IgG)IBA 05/2015 - 06/2009
2	Formaldehyde (Formol)FDA Link 04/2015 - 05/2014
2	ProteomeIBA 07/2014 - 05/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2011 - 10/2011
2	Vincristine (Oncovin)FDA LinkGeneric 10/2011 - 10/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2011 - 10/2011
2	temsirolimus FDA Link 04/2011 - 08/2008
2	TOR Serine-Threonine KinasesIBA 04/2011 - 08/2008
2	CytokinesIBA 07/2007 - 11/2005
2	Interleukin-12 (IL 12)IBA 10/2006 - 01/2002
2	ChemokinesIBA 08/2006 - 11/2002
2	ClusterinIBA 02/2005 - 08/2004
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2022
1	Lymphoid Enhancer-Binding Factor 1IBA 01/2022
1	CateninsIBA 01/2022
1	Extracellular Matrix ProteinsIBA 02/2021
1	Epidermal Growth Factor (EGF)IBA 02/2021
1	fibulinIBA 02/2021
1	EnzymesIBA 01/2020
1	Adenosine Monophosphate (AMP)IBA 01/2020
1	AnthracyclinesIBA 11/2018
1	Prealbumin (Transthyretin)IBA 11/2018
1	Tryptases (Tryptase)IBA 10/2018
1	Diflunisal (Dolobid)FDA Link 10/2018
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 10/2018
1	Periodic AcidIBA 09/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2017

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 10/2019 - 02/2004
6	Lasers (Laser) 10/2019 - 01/2013
6	Therapeutics 01/2016 - 04/2003
2	Radiotherapy 10/2019 - 10/2011
1	Maze Procedure 01/2020